Selected research
Industry Research
Pregnancy Medication Industry Research Report 2026
Market perspective
The global Pregnancy Medication market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pregnancy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pregnancy Medication is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pregnancy Medication is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pregnancy Medication include Janssen, Takeda, Sanofi, Pfizer, GSK, AbbVie, Viatris Inc(Mylan Inc.), Sun Pharma and Roche Holding AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pregnancy Medication market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pregnancy Medication Market by Company
Janssen
Takeda
Sanofi
Pfizer
GSK
AbbVie
Viatris Inc(Mylan Inc.)
Sun Pharma
Roche Holding AG
Regeneron
Piramal Enterprises Limited
Lupin Limited
Glenmark Pharmaceuticals Ltd
Dr. Reddy's Laboratories
Cipla Inc
Amgen Inc
Alkem Laboratories Limited
Alembic Pharmaceuticals Ltd
Pregnancy Medication Segment by Type
Antiallergic
Antimicrobials
Antianemia
Antacids
Laxatives
Vaccines
Nutritional Supplements
Analgesics
Others
Pregnancy Medication Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Pregnancy Medication Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregnancy Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pregnancy Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregnancy Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pregnancy Medication manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pregnancy Medication by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pregnancy Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antiallergic
- Antimicrobials
- Antianemia
- Antacids
- Laxatives
- Vaccines
- Nutritional Supplements
- Analgesics
- Others
Applications
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Companies covered
- Janssen
- Takeda
- Sanofi
- Pfizer
- GSK
- AbbVie
- Viatris Inc(Mylan Inc.)
- Sun Pharma
- Roche Holding AG
- Regeneron
- Piramal Enterprises Limited
- Lupin Limited
- Glenmark Pharmaceuticals Ltd
- Dr. Reddy's Laboratories
- Cipla Inc
- Amgen Inc
- Alkem Laboratories Limited
- Alembic Pharmaceuticals Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pregnancy Medication Market Size (2021-2032)
- 2.2.2 Global Pregnancy Medication Sales (2021-2032)
- 2.2.3 Global Pregnancy Medication Market Average Price (2021-2032)
- 2.3 Pregnancy Medication by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antiallergic
- 2.3.3 Antimicrobials
- 2.3.4 Antianemia
- 2.3.5 Antacids
- 2.3.6 Laxatives
- 2.3.7 Vaccines
- 2.3.8 Nutritional Supplements
- 2.3.9 Analgesics
- 2.3.10 Others
- 2.4 Pregnancy Medication by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pregnancy Medication Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pregnancy Medication Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pregnancy Medication Revenue of Manufacturers (2021-2026)
- 3.4 Global Pregnancy Medication Average Price by Manufacturers (2021-2026)
- 3.5 Global Pregnancy Medication Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pregnancy Medication, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pregnancy Medication, Product Type & Application
- 3.8 Global Manufacturers of Pregnancy Medication, Established Date
- 3.9 Global Pregnancy Medication Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Janssen
- 4.1.1 Janssen Company Information
- 4.1.2 Janssen Business Overview
- 4.1.3 Janssen Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Janssen Pregnancy Medication Product Portfolio
- 4.1.5 Janssen Recent Developments
- 4.2 Takeda
- 4.2.1 Takeda Company Information
- 4.2.2 Takeda Business Overview
- 4.2.3 Takeda Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Takeda Pregnancy Medication Product Portfolio
- 4.2.5 Takeda Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Pregnancy Medication Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Pregnancy Medication Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 GSK
- 4.5.1 GSK Company Information
- 4.5.2 GSK Business Overview
- 4.5.3 GSK Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GSK Pregnancy Medication Product Portfolio
- 4.5.5 GSK Recent Developments
- 4.6 AbbVie
- 4.6.1 AbbVie Company Information
- 4.6.2 AbbVie Business Overview
- 4.6.3 AbbVie Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AbbVie Pregnancy Medication Product Portfolio
- 4.6.5 AbbVie Recent Developments
- 4.7 Viatris Inc(Mylan Inc.)
- 4.7.1 Viatris Inc(Mylan Inc.) Company Information
- 4.7.2 Viatris Inc(Mylan Inc.) Business Overview
- 4.7.3 Viatris Inc(Mylan Inc.) Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Viatris Inc(Mylan Inc.) Pregnancy Medication Product Portfolio
- 4.7.5 Viatris Inc(Mylan Inc.) Recent Developments
- 4.8 Sun Pharma
- 4.8.1 Sun Pharma Company Information
- 4.8.2 Sun Pharma Business Overview
- 4.8.3 Sun Pharma Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sun Pharma Pregnancy Medication Product Portfolio
- 4.8.5 Sun Pharma Recent Developments
- 4.9 Roche Holding AG
- 4.9.1 Roche Holding AG Company Information
- 4.9.2 Roche Holding AG Business Overview
- 4.9.3 Roche Holding AG Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Roche Holding AG Pregnancy Medication Product Portfolio
- 4.9.5 Roche Holding AG Recent Developments
- 4.10 Regeneron
- 4.10.1 Regeneron Company Information
- 4.10.2 Regeneron Business Overview
- 4.10.3 Regeneron Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Regeneron Pregnancy Medication Product Portfolio
- 4.10.5 Regeneron Recent Developments
- 4.11 Piramal Enterprises Limited
- 4.11.1 Piramal Enterprises Limited Company Information
- 4.11.2 Piramal Enterprises Limited Business Overview
- 4.11.3 Piramal Enterprises Limited Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Piramal Enterprises Limited Pregnancy Medication Product Portfolio
- 4.11.5 Piramal Enterprises Limited Recent Developments
- 4.12 Lupin Limited
- 4.12.1 Lupin Limited Company Information
- 4.12.2 Lupin Limited Business Overview
- 4.12.3 Lupin Limited Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Lupin Limited Pregnancy Medication Product Portfolio
- 4.12.5 Lupin Limited Recent Developments
- 4.13 Glenmark Pharmaceuticals Ltd
- 4.13.1 Glenmark Pharmaceuticals Ltd Company Information
- 4.13.2 Glenmark Pharmaceuticals Ltd Business Overview
- 4.13.3 Glenmark Pharmaceuticals Ltd Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Glenmark Pharmaceuticals Ltd Pregnancy Medication Product Portfolio
- 4.13.5 Glenmark Pharmaceuticals Ltd Recent Developments
- 4.14 Dr. Reddy's Laboratories
- 4.14.1 Dr. Reddy's Laboratories Company Information
- 4.14.2 Dr. Reddy's Laboratories Business Overview
- 4.14.3 Dr. Reddy's Laboratories Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Dr. Reddy's Laboratories Pregnancy Medication Product Portfolio
- 4.14.5 Dr. Reddy's Laboratories Recent Developments
- 4.15 Cipla Inc
- 4.15.1 Cipla Inc Company Information
- 4.15.2 Cipla Inc Business Overview
- 4.15.3 Cipla Inc Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Cipla Inc Pregnancy Medication Product Portfolio
- 4.15.5 Cipla Inc Recent Developments
- 4.16 Amgen Inc
- 4.16.1 Amgen Inc Company Information
- 4.16.2 Amgen Inc Business Overview
- 4.16.3 Amgen Inc Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Amgen Inc Pregnancy Medication Product Portfolio
- 4.16.5 Amgen Inc Recent Developments
- 4.17 Alkem Laboratories Limited
- 4.17.1 Alkem Laboratories Limited Company Information
- 4.17.2 Alkem Laboratories Limited Business Overview
- 4.17.3 Alkem Laboratories Limited Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Alkem Laboratories Limited Pregnancy Medication Product Portfolio
- 4.17.5 Alkem Laboratories Limited Recent Developments
- 4.18 Alembic Pharmaceuticals Ltd
- 4.18.1 Alembic Pharmaceuticals Ltd Company Information
- 4.18.2 Alembic Pharmaceuticals Ltd Business Overview
- 4.18.3 Alembic Pharmaceuticals Ltd Pregnancy Medication Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Alembic Pharmaceuticals Ltd Pregnancy Medication Product Portfolio
- 4.18.5 Alembic Pharmaceuticals Ltd Recent Developments
5 Global Pregnancy Medication Market Scenario by Region
- 5.1 Global Pregnancy Medication Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pregnancy Medication Sales by Region: 2021-2032
- 5.2.1 Global Pregnancy Medication Sales by Region: 2021-2026
- 5.2.2 Global Pregnancy Medication Sales by Region: 2027-2032
- 5.3 Global Pregnancy Medication Revenue by Region: 2021-2032
- 5.3.1 Global Pregnancy Medication Revenue by Region: 2021-2026
- 5.3.2 Global Pregnancy Medication Revenue by Region: 2027-2032
- 5.4 North America Pregnancy Medication Market Facts & Figures by Country
- 5.4.1 North America Pregnancy Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pregnancy Medication Sales by Country (2021-2032)
- 5.4.3 North America Pregnancy Medication Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pregnancy Medication Market Facts & Figures by Country
- 5.5.1 Europe Pregnancy Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pregnancy Medication Sales by Country (2021-2032)
- 5.5.3 Europe Pregnancy Medication Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Pregnancy Medication Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pregnancy Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pregnancy Medication Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pregnancy Medication Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pregnancy Medication Market Facts & Figures by Country
- 5.7.1 South America Pregnancy Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pregnancy Medication Sales by Country (2021-2032)
- 5.7.3 South America Pregnancy Medication Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pregnancy Medication Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pregnancy Medication Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pregnancy Medication Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pregnancy Medication Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pregnancy Medication Sales by Type (2021-2032)
- 6.1.1 Global Pregnancy Medication Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pregnancy Medication Sales Market Share by Type (2021-2032)
- 6.2 Global Pregnancy Medication Revenue by Type (2021-2032)
- 6.2.1 Global Pregnancy Medication Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pregnancy Medication Revenue Market Share by Type (2021-2032)
- 6.3 Global Pregnancy Medication Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pregnancy Medication Sales by Application (2021-2032)
- 7.1.1 Global Pregnancy Medication Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pregnancy Medication Sales Market Share by Application (2021-2032)
- 7.2 Global Pregnancy Medication Revenue by Application (2021-2032)
- 7.2.1 Global Pregnancy Medication Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pregnancy Medication Revenue Market Share by Application (2021-2032)
- 7.3 Global Pregnancy Medication Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pregnancy Medication Value Chain Analysis
- 8.1.1 Pregnancy Medication Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pregnancy Medication Production Mode & Process
- 8.2 Pregnancy Medication Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pregnancy Medication Distributors
- 8.2.3 Pregnancy Medication Customers
9 Global Pregnancy Medication Analyzing Market Dynamics
- 9.1 Pregnancy Medication Industry Trends
- 9.2 Pregnancy Medication Industry Drivers
- 9.3 Pregnancy Medication Industry Opportunities and Challenges
- 9.4 Pregnancy Medication Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst